updates our to the Thanks, and second to joining I'll for Ryan, over cycle CFO, initiatives, including discuss our our I’ll financial our path call. the provide on quarter call on everyone and Kamal, our to results profitability. Today, turn details performance. thank revenue then you
on total Our resulted XX.X CTD and of strong AVISE million. CTD and AVISE quarter, strategy tests to over with another revenues delivered XX,XXX prioritize in focus has
we've As fact the sales to that team of reminder, continue made to rheumatology substantial a and that testament our effective size we the to community we structure performance changes manner. and is serve our a QX highly in the believe
decisions we in get also quarterly the to operational I'm this encouraged as Exagen improvements at we're reflected and the has to volume end last of our see see reinforces company the of performance the exciting to this we consecutive strategic make as a starting But team. progress opportunity It's growth really made our in business. to track quarter. ahead, significant on year.
quarter the quarters. in but for of cash reflective a result prior strong also and in revenue collections second testing QX, improved testing Our performed the demand from was volume delivered of
have We our QX operations in continue detail to our made to processes, and major I'll cycle heavily focus revenue on improve shortly. which strides
early improvement profitability seeing our incremental momentum our in cash believe into positive Overall, positive move as in see and to XXXX, ASP to we we're but to improvements sign. expect We these we efforts operations are achieve progress. a early collections in continue
recur expect in timing by to was the saw don't increase ASP, our QX key aided was prior necessarily from of trailing claims quarter-over-quarter improvement quarter. we increased where to The $XXX from periods, we which collections on cash $XXX. each of One XX-month metrics which
this a However, reflected the in development nonetheless improvement positive was ASP. in
into our XXXX. expect but efforts materialize we're the In in trend the to to general, of beginning direction, right bulk
of appeals. the we optimize appeal increase overall an our and to effort As time process, ourselves held including we persistence to to conveyed QX, claims in volume, give quality
writer restructured the every To the to to We've and worked process. with all we've on denied internal appeals area a of process in business. to person some responsibilities brought the claims. technical our roles team, letters payers efforts color We've revise give of involved redefining with extent our leadership on this to date, new in appeal our sent for
advice. they in increase our worked companies, the We've improve to allowing rationale to outbound on lessen calls the staff. to the clinical to our ordering to other clients our team with appeal with to brought burden and improve on the status. these us for keep exchanging progress to notes for customer our better the track process notes each patient draft communicate of worked utilizing We've We insurance personnel better
testing the strengthen to compared efficiently these of manner have still progress seen the and ago. the for XX ordering a even doing last in customers adjustment disruption this been which a reinforces with with execute our documentation And continues. changes. around requires AVISE value and what they've substantial communication All the resetting we're efforts expectations making years. and list months test We were with to six we These minimizes
loan million. We refinanced included profitable business. this continue our achieving a a which principal focus to payment quarter, We on of $XX
revenue changes our million. by accounts to management receivable X.X increased Our cycle
these second Excluding X.X items, two the million our decreased quarter. cash in
team operate the the a service organization, deliver to We effective progress Exagen the markedly are in and structure. in improved striving areas to a leaner, making all with of at is cost best as industry the company more
Additionally, expected QX of we expenses expect by continue to timing aided million, R&D the to performance these and our of was approach our some expenses. therefore X annual
ancillary we initiated conduct investigation was occurred related XXXX. recently in XXXX of investigation to of in February As Department an This settle XXXX. the that was an and reached an to in item, principle agreement with that Justice
so The we ultimately, operating us going behind can to subject and we liability. is on a our look business. payment require approximately negotiations. this to fees to did monitor agreement settlement definitive with operations putting associated to of outside not focus agreed We admitted to continue facts, an principle oversee we $XXX,XXX The settlement issue certain further forward not although will in make DoJ to forward. the But compliance concede
rheumatology is In quarter to testament closing, our where see of it's hard Exagen direction. AVISE to work the see trending that recent results and right and very continue improve encouraged to the we performance value many rewarding provides is team performance, have to This yet community. in another the by several areas organizational ongoing knowing the testing from in the I'm our the efforts.
retired Jim personally. Jim has of I support the for the a and me the meeting for throughout the member a call I annual and Kamal, years Jim team. him note strong hand Exagen and the a Jim to of to on guidance vital a of history, Board as nine that member had our of we Before Board over his past I'd like to this well. Tullis director quarter, Directors. at of been company's wish Exagen to supportive want thank much been
Paul warm and played Paul a our and growing profitable Additionally, Kim, Genetics, CFO member where of pivotal in Board. as role vast I'd to business to newest like a us leadership a experience he and Fulgent business. successful welcome the of into joins with extend the currently serves the company
call Kamal. I'll to over now turn the